Outsourcing

Articles

The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.

Hitachi Chemical to Acquire apceth Biopharma

Barrett Fallentine is director of Product and Process Development, Pharmatech Associates, bfallentine@pai-qbd.com. 

Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.

Mind the Gap: Tech Transfer from Early Stage Cell Culture to Phase I Clinical Manufacture

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Outsourcing of analytical testing and processes can help bio/pharmaceutical companies expand their product profiles. 

Utilizing Analytical Services for Success in Innovation

Pharmaceutical Technology spoke with John Pirro, senior director of large molecule bioanalysis at WuXi AppTec, which provides anti-drug antibody (ADA) and neutralizing antibody (Nab) assay development, validation, and sample analysis services, about best practices to ensure that biologics are safe and effective.

Best Practices for Immunogenicity Testing of Biologics

Amber Lowry is an associate editor at UBM plc.

Suppliers set the tone for 2019 with strategic expansions, investments, and acquisitions.

CMO Expansions and Investments

Guillame Plane is global development and marketing manager for  MilliporeSigma's BioReliance End-to-End Solutions.

Only careful planning can prevent problems that stem from differences between a sponsor’s and a CDMO’s equipment, practices, and culture. This article highlights best practices and case studies.

A Systematic Approach to Tech Transfer and Scale-Up

Full commercial launch of the drug is underway in the United States, with Europe to follow.

Lonza Launches Commercial Supply of Second-Gen Andexxa

The company will invest $4 million to increase topical and transdermal formulation development and performance testing services at its Durham, NC, facility.

MedPharm Expands US Center of Excellence

The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.

Catalent Invests $200 Million in Wisconsin and Indiana Sites

Fujifilm increases capacity of its Bio-CDMO business with an expansion of production in North Carolina.

Contract Manufacturing Services